A recent parliamentary panel report underscores the critical need to expedite the inclusion of the Human Papillomavirus (HPV) vaccine in the Universal Immunisation Programme (UIP) across all Indian states and Union Territories. This crucial step aims to significantly reduce cervical cancer incidence and also improve women’s health outcomes. Cervical cancer is a prevalent cancer among women in India, and the HPV vaccine has demonstrated proven effectiveness in its prevention.
Addressing the Need for HPV Vaccine India
The Committee on Petitions, Rajya Sabha, led by Narain Dass Gupta, submitted its report advocating for swift action. The Union Budget 2024 notably prioritized the phased introduction of the vaccine. Furthermore, the National Technical Advisory Group on Immunisation (NTAGI) recommended its inclusion in the UIP for girls aged 9-14 years. Unfortunately, the rollout has commenced only in Sikkim and Bihar, and thus the vaccine is yet to be fully integrated into the national immunisation schedule.
Cervical cancer remains a significant public health challenge in India, accounting for a substantial number of cancer cases and deaths among women annually. Studies show that India contributes to a large proportion of the global cervical cancer burden. The indigenous quadrivalent HPV vaccine (Cervavac), manufactured by the Serum Institute of India, was approved in 2023, offering a more affordable option.
Strengthening Screening and Awareness Initiatives
Given the country’s low rate of cancer screening, the Committee further recommended that the government scale up the national screening programme. This initiative should particularly focus on regions with limited access to medical care. Beyond expanding screening infrastructure, the government must intensify awareness campaigns nationwide. These campaigns must be region-specific, ensuring maximum outreach, rather than being generalized.
Engaging non-government organizations (NGOs) is also vital, as they understand ground realities and possess valuable experience working with local communities. Leveraging these partnerships effectively supplements government efforts in conveying preventive messages, especially considering the social stigma associated with cancer in many parts of India. Utilizing celebrities, particularly cancer survivors, can further emphasize the importance of early screening.
Enhancing Healthcare Infrastructure and Training
To strengthen district-level health facilities, the Committee suggested up-skilling doctors at primary and secondary healthcare centers through targeted training programmes. Moreover, it highlighted the necessity to enhance the skills of nurses and technicians involved in cancer care delivery. The report also noted the underdeveloped radiotherapy infrastructure in India, with most critical equipment being imported. This consequently makes procedures prohibitively expensive for many individuals. Prioritizing the domestic manufacturing of PET scan equipment is therefore a key recommendation from the panel.
Frequently Asked Questions
Q1: Why is the HPV vaccine’s inclusion in India’s Universal Immunisation Programme so important?
The HPV vaccine is crucial for inclusion in India’s UIP because cervical cancer is the most common cancer among women in the country, and the vaccine has proven highly effective in its prevention. Its widespread introduction will significantly reduce cervical cancer incidence and improve women’s health outcomes.
Q2: What challenges does India face in rolling out the HPV vaccine nationally?
The primary challenge is the slow pace of rollout, with the vaccine currently integrated only in Sikkim and Bihar despite recommendations for national inclusion. Additionally, the availability and affordability of vaccines, particularly for a large-scale program, have been considerations, although an indigenous vaccine (Cervavac) is now available.
Q3: Besides vaccination, what other measures are recommended to combat cervical cancer in India?
The parliamentary panel recommends scaling up national screening programs, especially in underserved regions, intensifying region-specific awareness campaigns, actively involving NGOs, utilizing celebrity cancer survivors for advocacy, and up-skilling healthcare professionals in cancer care.
References
- HPV vaccine must be added to Universal Immunisation Programme to cut cervicalcancer risk: Parl panel – ETHealthworld
- Cervical Cancer in India – prescrip-tec
- HPV vaccine must be added to Universal Immunisation Programme to cut cervical cancer risk: Parl panel – Justdial
- HPV vaccine must be added to Universal Immunisation Programme to cut cervical cancer risk: Parl panel – The Economic Times
- HPV vaccine to be rolled out in a few months time: Top health ministry official
- India prepares to introduce HPV vaccine in National Immunization Program – HPV World
- Burden of cervical cancer and role of screening in India – PMC – PubMed Central
- Cervical cancer in India: challenges and opportunities
- Health Talk | HPV vaccine may finally be making its way into the government’s Universal Immunisation Programme
- Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019
- India: Human Papillomavirus and Related Cancers, Fact Sheet 2023 – HPV INFORMATION CENTRE
- Challenges in HPV vaccine introduction in India – an evidence-based, pragmatic solution
- Centre urges States to create awareness and take steps for prevention of cervical cancer among girl students – PIB
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.